A breakthrough in the quest to find a blood test for Alzheimer's will help doctors and patients "manage the disease", one of the researchers has said.
Professor Howard Federoff explained:
Our novel blood test offers the potential to identify people at risk for progressive cognitive decline and can change how patients, their families and treating physicians plan for and manage the disorder.
The preclinical state of the disease offers a window of opportunity for timely disease-modifying intervention.
Biomarkers such as ours that define this asymptomatic period are critical for successful development and application of these therapeutics.
We consider our results a major step toward the commercialisation of a preclinical disease biomarker test.
More top news
Jessica Bamford's parents rushed her to hospital after a 'white hard substance' formed around her mouth but luckily she did not swallow it.
Nine in 10 emergency services personnel have experienced stress, low mood and poor mental health, according to a recent survey.
An ancient ocean on the surface of Mars held more liquid water than the Earth's Arctic Ocean, scientists believe.